Published September 16, 2026
The long-delayed final approval hearing for Bayer's proposed $7.25 billion Roundup class settlement finally took place on September 14, 2026, before Judge Timothy Boyer in Missouri Circuit Court in St. Louis. Boyer heard arguments from both sides but did not issue a ruling from the bench, leaving the settlement's fate undecided for now.
The settlement is designed to resolve roughly 65,000 pending Roundup claims in state and federal courts nationwide, with individual payouts for non-Hodgkin lymphoma diagnoses reportedly ranging from $10,000 to $165,000 depending on the severity of the case. Attorneys supporting the deal argued it guarantees compensation at a time when litigation outcomes have become less certain following the U.S. Supreme Court's June 2026 ruling in Monsanto's favor on federal preemption grounds. Objecting plaintiffs' attorneys countered that the settlement undervalues claims and is structured to discourage claimants from opting out to pursue their cases individually in court.
This hearing had already been rescheduled once, from an original date in August, after the settlement administrator reported a wave of claimants who had previously opted out of the deal seeking to revoke those opt-outs — a shift attorneys have linked to the Supreme Court's preemption ruling narrowing plaintiffs' options outside the settlement. That delay pushed the proceeding to September 14, and Boyer's decision to take the matter under advisement rather than rule immediately means claimants and objectors alike are now waiting on a written decision with no announced timeline.
If you or a family member were diagnosed with non-Hodgkin lymphoma after regular Roundup exposure, see Atumio's Roundup case page for a free eligibility review, or start your case review directly.